AVIDITY PARTNERS MANAGEMENT LP
other names
- AVIDITY PARTNERS MANAGEMENT LP
Adviser Profile
|
Exempt Reporting Adviser
2B(3)- PF>150mn
|
|
| Private Fund GAV* | 0 |
| SMA’s | No |
| Private Funds | 0 1 |
Private Funds
Employees
Top Holdings
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$176,583,121 | % Position36.00% | $ Change104.00% | # Change0.00% |
| Stck Ticker156944100 | Stock NameCG ONCOLOGY INC | $ Position$87,236,001 | % Position18.00% | $ Change43.00% | # Change-12.00% |
| Stck Ticker687604108 | Stock NameORUKA THERAPEUTICS INC | $ Position$37,298,797 | % Position8.00% | $ Change86.00% | # Change15.00% |
| Stck Ticker46489V302 | Stock NamePERSPECTIVE THERAPEUTICS INC | $ Position$25,228,496 | % Position5.00% | $ Change186.00% | # Change88.00% |
| Stck Ticker008064206 | Stock NameJADE BIOSCIENCES INC | $ Position$19,679,947 | % Position4.00% | $ Change-9.00% | # Change0.00% |
| Stck Ticker21077P108 | Stock NameCONTEXT THERAPEUTICS INC | $ Position$13,095,460 | % Position3.00% | $ Change62.00% | # Change-9.00% |
| Stck Ticker29337E102 | Stock NameENLIVEN THERAPEUTICS INC | $ Position$15,680,000 | % Position3.00% | $ Change626.00% | # Change185.00% |
| Stck Ticker881624209 | Stock NameTEVA PHARM ADR | $ Position$13,557,012 | % Position3.00% | $ Change4.00% | # Change8.00% |
| Stck Ticker92764N102 | Stock NameVIR BIOTECHNOLOGY INC | $ Position$8,512,000 | % Position2.00% | $ Change | # Change |
| Stck Ticker01021M104 | Stock NameAKTIS ONCOLOGY INC | $ Position$8,382,646 | % Position2.00% | $ Change | # Change |